Showing 1,401 - 1,420 results of 17,928 for search 'significant ((((gap decrease) OR (((step decrease) OR (teer decrease))))) OR (a decrease))', query time: 0.72s Refine Results
  1. 1401

    Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma <i>In Vivo</i> by Mingyue Li (1582399)

    Published 2025
    “…The probe exhibits a consistent decrease in fluorescence intensity with an increase in solvent polarity, demonstrating excellent photostability and biocompatibility. …”
  2. 1402
  3. 1403
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408
  9. 1409
  10. 1410

    <i>Aedes aegypti</i> database from SAGO traps. by Jesús A. Aguilar-Durán (9931967)

    Published 2025
    “…</p><p>Conclusion</p><p>Despite all treatments followed a reduction in mosquito populations, those that included AGO showed a greater decrease in post treatment populations than conventional control measures (IVM) alone. …”
  11. 1411
  12. 1412
  13. 1413
  14. 1414
  15. 1415

    Conceptual framework to guide the study. by Resham B. Khatri (10949429)

    Published 2025
    “…From 2011 to 2022, there were increased institutional deliveries overall (47% to 81%) and CS within private HFs (30% to 51%), alongside a decreasing trend in the utilization of maternity incentives (87% to 78%). …”
  16. 1416

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”
  17. 1417

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”
  18. 1418

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”
  19. 1419
  20. 1420